Ocean Biomedical, Inc. (OCEA) Key Metrics
OCEA valuation today
Trailing 12 months · as of October 21, 2026- Market cap
- $116,182
- Enterprise value
- $9.6M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 100.7
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.38
OCEA key metrics, 2019–2024
Fiscal year ended December 31, 2024 · U.S. dollarsOCEA returns How much profit the business earns on the capital it uses.
OCEA financial health Debt, liquidity and how easily interest is covered.
OCEA returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
OCEA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
OCEA cash returned to shareholders
OCEA key metrics
2019–2024| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Share price at fiscal year-end | $0.55 | $0.66 | $10.40 | $9.99 | — | — |
| Returns & profitability | ||||||
| Return on equity (ROE) | — | — | 0.5% | −120.6% | — | — |
| Return on invested capital (ROIC) | — | — | −1.9% | −96.3% | — | — |
| Return on assets (ROA) | −103.1% | −196.7% | 0.5% | −114.4% | −856.5% | — |
| Return on tangible assets | −366.0% | — | 0.5% | −57.4% | −428.2% | — |
| Income quality (OCF / net income) | — | — | −1.32 | — | — | — |
| Financial health | ||||||
| Total debt | $16.3M | $12.1M | $2.1M | — | — | — |
| Cash & short-term investments | $224,000 | $4,000 | $328,305 | $1.1M | — | — |
| Net debt | $16.1M | $12.1M | $1.8M | −$1.1M | — | — |
| Debt / equity | — | — | 0.02 | — | — | — |
| Debt / assets | 18.07 | 2.20 | 0.02 | — | — | — |
| Current ratio | 0.02 | 0.07 | 0.14 | 6.29 | 0.17 | 0.00 |
| Quick ratio | 0.02 | 0.07 | 0.14 | 6.29 | 0.17 | 0.00 |
| Interest coverage | -1.9 | -5.8 | — | — | — | — |
| Working capital | −$33.1M | −$27.9M | −$3.0M | $1.3M | −$1.9M | −$232,000 |
| Invested capital | −$81.5M | −$78.6M | $106.1M | $104.2M | −$1.9M | −$232,000 |
| Tangible asset value | −$97.6M | −$90.8M | $104.3M | $105.3M | −$1.9M | −$232,000 |
| Net current asset value | −$97.7M | −$94.2M | −$6.1M | −$1.8M | −$1.9M | −$232,000 |
| Capital allocation | ||||||
| Share buybacks (net) | $0 | $64.3M | $0 | — | — | — |
| Capex / depreciation | — | — | 0.00 | 0.00 | — | 0.00 |
| Efficiency | ||||||
| Receivables turnover | — | — | 0.00 | — | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Average receivables | — | — | $50,000 | — | — | — |
| Average payables | $866,000 | $738,500 | $289,222 | $43,722 | $142,500 | $232,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Computed from OCEA's annual financial statements (latest annual report filed April 8, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
OCEA valuation and financial ratios
It ended the year with $16.3 million of debt and $0.2 million in cash and short-term investments, net debt of $16.1 million.
See the OCEA income statement, the OCEA chart for price history, or the OCEA stock overview for the latest quote and news.
OCEA key metrics FAQ
How much debt does Ocean Biomedical have?
Ocean Biomedical had total debt of $16.3 million at the end of fiscal 2024.
What is Ocean Biomedical's current ratio?
Ocean Biomedical's current ratio was 0.02 at the end of fiscal 2024: current assets were 0.02 times current liabilities.